Anthony Turpin

2.8k total citations
109 papers, 777 citations indexed

About

Anthony Turpin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anthony Turpin has authored 109 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Anthony Turpin's work include Pancreatic and Hepatic Oncology Research (28 papers), Colorectal Cancer Treatments and Studies (27 papers) and Gastric Cancer Management and Outcomes (18 papers). Anthony Turpin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Colorectal Cancer Treatments and Studies (27 papers) and Gastric Cancer Management and Outcomes (18 papers). Anthony Turpin collaborates with scholars based in France, United States and Spain. Anthony Turpin's co-authors include Cindy Neuzillet, Mehdi El Amrani, Jean‐Baptiste Bachet, Martine Duterque‐Coquillaud, Marie-Hélène Vieillard, Nicolas Penel, Alice Boilève, Pascal Hammel, Nicolas Simon and Stéphanie Truant and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anthony Turpin

93 papers receiving 768 citations

Peers

Anthony Turpin
Kelsey C. Stoltzfus United States
J. Bernhard Switzerland
Reuben Broom New Zealand
Roger Allison Australia
Kelsey C. Stoltzfus United States
Anthony Turpin
Citations per year, relative to Anthony Turpin Anthony Turpin (= 1×) peers Kelsey C. Stoltzfus

Countries citing papers authored by Anthony Turpin

Since Specialization
Citations

This map shows the geographic impact of Anthony Turpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Turpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Turpin more than expected).

Fields of papers citing papers by Anthony Turpin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Turpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Turpin. The network helps show where Anthony Turpin may publish in the future.

Co-authorship network of co-authors of Anthony Turpin

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Turpin. A scholar is included among the top collaborators of Anthony Turpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Turpin. Anthony Turpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pigneur, F., Marc Hilmi, Dewi Vernerey, et al.. (2025). Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13595–e13595. 2 indexed citations
2.
Maurage, Claude‐Alain, et al.. (2025). High-grade gliomas and Lynch syndrome: A retrospective descriptive study with a literature review. Neuro-Oncology Practice. 13(1). 139–148.
4.
Dusetti, Nelson, Jean‐Baptiste Bachet, Brice Chanez, et al.. (2025). Medical management of pancreatic cancer: from personalization to broadening treatment strategies. Cancer Treatment Reviews. 138. 102973–102973. 2 indexed citations
5.
Hilmi, Marc, Anthony Turpin, Antoine Andremont, et al.. (2024). Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study. Digestive and Liver Disease. 57(1). 89–96. 1 indexed citations
6.
Bertrand, Nicolas, et al.. (2023). Preserving bone in cancers of the elderly: A necessity. Joint Bone Spine. 90(4). 105549–105549. 1 indexed citations
7.
Gallois, Claire, Édouard Auclin, Elisabeth Bergen, et al.. (2023). 625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study. Annals of Oncology. 34. S446–S446. 4 indexed citations
8.
Ningarhari, Massih, Nicolas Bertrand, Christophe Desauw, et al.. (2023). Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case–control study. Liver International. 44(3). 682–690.
9.
Chiaravalli, Marta, Anthony Turpin, Florian Castet, et al.. (2023). Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis. SHILAP Revista de lepidopterología. 2. 100011–100011.
10.
Turpin, Anthony, Anne Flourens, Xavier Leroy, et al.. (2023). Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor. British Journal of Cancer. 129(12). 1903–1914. 3 indexed citations
11.
Edeline, Julien, Julie Henriques, Héloïse Bourien, et al.. (2023). 119P Management of biliary tract cancers in older patients: A French multicenter cohort study. Annals of Oncology. 34. S226–S227. 1 indexed citations
12.
Drouillard, Antoine, Émilie Soularue, Olivier Dubreuil, et al.. (2023). Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study. Digestive and Liver Disease. 56(1). 198–205. 1 indexed citations
13.
Benoist, Stéphane, Patrick Devos, Stéphanie Truant, et al.. (2022). Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World Journal of Surgical Oncology. 20(1). 131–131. 15 indexed citations
14.
Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902. 2 indexed citations
16.
Turpin, Anthony, et al.. (2022). Soins de support nutritionnels dans le parcours des patients atteints de cancers œsogastriques. Bulletin du Cancer. 110(5). 540–551. 4 indexed citations
17.
Béhal, Hélène, Loïc Lebellec, Simon Baldacci, et al.. (2021). Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study. Cancer Chemotherapy and Pharmacology. 87(4). 533–541. 3 indexed citations
18.
Hilmi, Marc, et al.. (2020). Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey. Clinical Cancer Research. 26(18). 1 indexed citations
19.
Cohen, Romain, Elie Rassy, Magali Svrcek, et al.. (2020). A comprehensive overview of promising biomarkers in stage II colorectal cancer. Cancer Treatment Reviews. 88. 102059–102059. 15 indexed citations
20.
Lièvre, Astrid, Anthony Turpin, Isabelle Laure Ray-Coquard, et al.. (2020). 1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management. Annals of Oncology. 31. S993–S993. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026